0000899243-20-021585.txt : 20200805
0000899243-20-021585.hdr.sgml : 20200805
20200805215506
ACCESSION NUMBER: 0000899243-20-021585
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20200803
FILED AS OF DATE: 20200805
DATE AS OF CHANGE: 20200805
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: VAN BEEK JEROEN B
CENTRAL INDEX KEY: 0001743662
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-39409
FILM NUMBER: 201079558
MAIL ADDRESS:
STREET 1: C/O TRICIDA, INC.
STREET 2: 7000 SHORELINE COURT, SUITE 201
CITY: SOUTH SAN FRANCISCO
STATE: CA
ZIP: 94080
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Allovir, Inc.
CENTRAL INDEX KEY: 0001754068
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
IRS NUMBER: 831971007
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 139 MAIN STREET, SUITE 500
CITY: CAMBRIDGE
STATE: MA
ZIP: 02142
BUSINESS PHONE: (617) 433-2605
MAIL ADDRESS:
STREET 1: 139 MAIN STREET, SUITE 500
CITY: CAMBRIDGE
STATE: MA
ZIP: 02142
FORMER COMPANY:
FORMER CONFORMED NAME: ViraCyte, Inc.
DATE OF NAME CHANGE: 20180924
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2020-08-03
0
0001754068
Allovir, Inc.
ALVR
0001743662
VAN BEEK JEROEN B
C/O ALLOVIR, INC.
139 MAIN STREET, SUITE 500
CAMBRIDGE
MA
02142
0
1
0
0
Chief Commercial Officer
Common Stock
2020-08-03
4
C
0
6710
A
521640
D
Common Stock
2020-08-03
4
P
0
3000
17.00
A
524640
D
Series B Convertible Preferred Stock
2020-08-03
4
C
0
10000
D
Common Stock
6710
0
D
Each share of convertible preferred stock automatically converted into the Issuer's Common Stock on a one-for-1.49021 basis upon the closing of the Issuer's initial public offering on August 3, 2020 and had no expiration date.
/s/ Brett Hagen, as Attorney-in-Fact
2020-08-05